- Filed
- May 14, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 7, 2024 | 5.77M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2024 | 8.61M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 317.55K sh |
| Operating Cash Flow | Q1 2024 · Mar 31, 2024 | −$2.02M |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$4.8M |
| Long Term Debt | Q1 2024 · Mar 31, 2024 | $669K |
| Long Term Debt | Q1 2024 · Dec 31, 2023 | $1.24M |
| Short Term Debt | Q1 2024 · Mar 31, 2024 | $1.63M |
| Short Term Debt | Q1 2024 · Dec 31, 2023 | $1.03M |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $4.94M |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $4.96M |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | $3.07M |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | $2.69M |
| Stockholders Equity | Q1 2024 · Mar 31, 2023 | −$1.09M |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | $2.98M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $3.31M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $3.27M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $4M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $4.54M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $5.75M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $5.76M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $7.07M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $7.22M |
| Eps Diluted | Q1 2024 · Mar 31, 2024 | −$0.88 |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | −$13.81 |
| Eps Basic | Q1 2024 · Mar 31, 2024 | −$0.88 |
| Eps Basic restated | Q1 2024 · Mar 31, 2023 | −$13.81 |
| Sga Expense | Q1 2024 · Mar 31, 2024 | $1.47M |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $1.95M |
| Rd Expense | Q1 2024 · Mar 31, 2024 | $455K |
| Rd Expense | Q1 2024 · Mar 31, 2023 | $1.45M |
| Net Income | Q1 2024 · Mar 31, 2024 | −$2.11M |
| Net Income | Q1 2024 · Mar 31, 2023 | −$4.39M |
| Operating Income | Q1 2024 · Mar 31, 2024 | −$2.03M |
| Operating Income | Q1 2024 · Mar 31, 2023 | −$4.36M |
| Cost Of Revenue | Q1 2024 · Mar 31, 2024 | $12K |
| Cost Of Revenue | Q1 2024 · Mar 31, 2023 | $9K |
| Capex | Q1 2024 · Mar 31, 2023 | $39K |